iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value

$0.71−0.03 (-3.81%)

Close on Nov 11, 2026Market cap $1.79MP/E –Yield –

iSpecimen profit margin

Profit margin (net margin) is net income as a percentage of revenue.

iSpecimen's profit margin for the twelve months ending Jun 30, 2026 was -2449.0%. For fiscal 2025 it was -543.7%, against -134.5% the year before. The highest annual figure on record is -56.8% in fiscal 2020.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-543.7%	−409.2
FY2024	Dec 31, 2024	-134.5%	−22.7
FY2023	Dec 31, 2023	-111.8%	−13.3
FY2022	Dec 31, 2022	-98.5%	−18.0
FY2021	Dec 31, 2021	-80.5%	−23.6
FY2020	Dec 31, 2020	-56.8%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-896.9%	−750.1
Q1 FY2026	Mar 31, 2026	-1458.4%	−1301.6
Q4 FY2025	Dec 31, 2025	-9662.2%	−9252.4
Q3 FY2025	Sep 30, 2025	-2608.7%	−2554.6
Q2 FY2025	Jun 30, 2025	-146.9%	−73.2
Q1 FY2025	Mar 31, 2025	-156.8%	−30.1
Q4 FY2024	Dec 31, 2024	-409.8%	−290.5
Q3 FY2024	Sep 30, 2024	-54.1%	+21.9
Q2 FY2024	Jun 30, 2024	-73.6%	+140.7
Q1 FY2024	Mar 31, 2024	-126.7%	−44.3
Q4 FY2023	Dec 31, 2023	-119.3%	−46.4
Q3 FY2023	Sep 30, 2023	-76.0%	+43.8
Q2 FY2023	Jun 30, 2023	-214.4%	−102.9
Q1 FY2023	Mar 31, 2023	-82.4%	+12.2
Q4 FY2022	Dec 31, 2022	-72.9%	+7.5
Q3 FY2022	Sep 30, 2022	-119.8%	−62.7
Q2 FY2022	Jun 30, 2022	-111.5%	−63.4
Q1 FY2022	Mar 31, 2022	-94.6%	+39.1
Q4 FY2021	Dec 31, 2021	-80.4%	−21.8
Q3 FY2021	Sep 30, 2021	-57.1%	−1.7
Q2 FY2021	Jun 30, 2021	-48.0%	−36.5
Q1 FY2021	Mar 31, 2021	-133.7%	–
Q4 FY2020	Dec 31, 2020	-58.6%	–
Q3 FY2020	Sep 30, 2020	-55.4%	–
Q2 FY2020	Jun 30, 2020	-11.6%	–